Although its expression is strongly upregulated at the hypoxic invasive front in breast cancers samples [20], we did not observe significant difference in the expression levels of the new JAG2 transcript in BC cells vs. non-tumoral cell line (Figure 3D). Here, JAG2 is linked to breast carcinoma.